Welcome to LookChem.com Sign In|Join Free
  • or
6-(1H-indol-4-yl)-4-(5-((4-isopropylpiperazin-1-yl)methyl)oxazol-2-yl)-1H-indazole is a complex indazole derivative featuring an indole ring, an oxazole ring, and a piperazine group, which classifies it as a heterocyclic compound. Its intricate chemical structure suggests potential pharmacological activity due to the presence of aromatic and heterocyclic rings, making it a promising candidate for medicinal chemistry and drug discovery research.

1254036-71-9

Post Buying Request

1254036-71-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1254036-71-9 Usage

Uses

Used in Pharmaceutical Industry:
6-(1H-indol-4-yl)-4-(5-((4-isopropylpiperazin-1-yl)methyl)oxazol-2-yl)-1H-indazole is used as a potential pharmaceutical agent for its possible interaction with biological systems. 6-(1H-indol-4-yl)-4-(5-((4-isopropylpiperazin-1-yl)methyl)oxazol-2-yl)-1H-indazole's unique structure allows it to be a candidate for further studies in drug discovery, potentially leading to the development of new medications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 6-(1H-indol-4-yl)-4-(5-((4-isopropylpiperazin-1-yl)methyl)oxazol-2-yl)-1H-indazole serves as a subject for investigation. Its heterocyclic nature and the presence of multiple rings make it an interesting molecule to explore for its potential therapeutic properties and mechanisms of action.

Check Digit Verification of cas no

The CAS Registry Mumber 1254036-71-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,4,0,3 and 6 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1254036-71:
(9*1)+(8*2)+(7*5)+(6*4)+(5*0)+(4*3)+(3*6)+(2*7)+(1*1)=129
129 % 10 = 9
So 1254036-71-9 is a valid CAS Registry Number.

1254036-71-9Relevant academic research and scientific papers

Application of C-H Functionalization in the Development of a Concise and Convergent Route to the Phosphatidylinositol-3-kinase Delta Inhibitor Nemiralisib

Bream, Robert N.,Clark, Hugh,Edney, Dean,Harsanyi, Antal,Hayler, John,Ironmonger, Alan,Mc Cleary, Nadine,Phillips, Natalie,Priestley, Catherine,Roberts, Alastair,Rushworth, Philip,Szeto, Peter,Webb, Michael R.,Wheelhouse, Katherine

, p. 529 - 540 (2021/03/01)

This paper describes the development of an improved and scalable method for the manufacture of nemiralisib, a phosphatidylinositol-3-kinase delta inhibitor. Incorporation of three consecutive catalytic reactions, including a palladium-catalyzed C-H functionalization and an iridium-catalyzed borylation, significantly simplified and shortened the synthetic sequence. The revised route was successfully implemented in a pilot plant on a multikilogram scale to deliver >100 kg of product.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1254036-71-9